Executive Interview – VolitionRx

Executive Interview – VolitionRx

VolitionRx (VNRX) is an international life sciences company developing simple, easy-to-use, blood-based cancer tests to accurately diagnose a range of cancers. In this interview, president and CEO Cameron Reynolds discusses last week’s earnings and looks forward to forthcoming milestones for 2017.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free